After spending years and hundreds of millions of dollars, Johnson and Johnson has won FDA approval for its new surgical robot Ottava. Can it challenge the dominance of competitors who entered the race years earlier, or is the market already spoken for? (Source: Bloomberg)
Comments (0)
Leave a Comment
No comments yet. Be the first to comment!